iShares Hang Seng Tech ETF (03067.HK) Rose 0.49% to 10.290 HKD
Newtimespace News, as of 10:25 on May 21, iShares Hang Seng Tech ETF (03067.HK) was quoted at HKD 10.290, up 0.49%. The ETF opened at HKD 10.350, with a high of HKD 10.380 and a low of HKD 10.270. The latest Net Asset Value (NAV) per unit is HKD 10.245, with a premium rate of -0.05%. The asset size is approximately HKD 15.218 billion.
iShares Hang Seng Tech ETF (03067.HK) tracks the Hang Seng Tech Index, which is compiled and published by Hang Seng Indexes Company Limited. The index aims to measure the performance of the 30 largest Hong Kong-listed companies that are highly related to the technology theme after screening. It mainly covers areas such as the internet, fintech, cloud, e-commerce, and digital businesses, and is known as the "Hong Kong version of Nasdaq".
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- VSING (08292.HK): Proposes Acquisition of Equity Interest in Golfzon Hong Kong to Build "Technology + Sports + Social" Entertainment Experience
- HK SH ALLIANCE (01001.HK): Subsidiary Unsuccessful in Tender for Tsing Yi Advanced Construction Industry Building Project
- BAIYUNSHAN PH (00874.HK): Dexamethasone Sodium Phosphate Injection (1ml:5mg) of Controlled Subsidiary Passes Generic Consistency Evaluation
- CI FIN TECH GP (08029.HK): Executive Director Wang Qiang Appointed Chairman of the Board; Zheng Meicheng Appointed Vice-chairwoman
- Shaanxi Micot Pharmaceutical Technology Co., Ltd (02335.HK): Phase II Clinical Study of Dual-Function Antithrombotic Candidate MT1002 for Anticoagulation in Haemodialysis Completes First Patient Enrolment